This article is a correction to:
Editorial: Emerging SARS-CoV-2 variants: Genomic variations, transmission, pathogenesis, clinical impact and interventions
Pragya D. Yadav
Sanjay Kumar
Éric Bergeron
Meerjady Sabrina Flora- 1Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
- 2Department of Neurosurgery, Command Hospital (Southern Command), Armed Forces Medical College (AFMC), Pune, India
- 3Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States
- 4Directorate General of Health Services, Dhaka, Bangladesh
A corrigendum on
Editorial: Emerging SARS-CoV-2 variants: genomic variations, transmission, pathogenesis, clinical impact and interventions
by Yadav, P. D., Kumar, S., Bergeron, É., and Flora, M. S. (2023). Front. Med. 10:1178696. doi: 10.3389/fmed.2023.1178696
In the published article, there was an error. “ORF8” was incorrectly written as “ORF8a”.
A correction has been made to Paragraph Number 3. This sentence previously stated: “All these studies revealed different mutational patterns and their impact on diagnostics, their role in immune evasion, pathogenesis, and advanced research on current vaccines and therapeutics, i.e., the emergence of Variants of Concern and Variants of Interest, novel mutations, rare double-deletion variation in the spike region (68-76del+spike 675–679del), dynamism in intrahost single nucleotide variants (iSNVs) in the severe and mild infection cohorts, immune evasion of the Mu variant and a derivative of the Delta strain with E484K and N501Y mutations, increased virulence and transmission, and the functional role of ORF8a in viral pathogenesis.”
The corrected sentence appears below: “All these studies revealed different mutational patterns and their impact on diagnostics, their role in immune evasion, pathogenesis, and advanced research on current vaccines and therapeutics, i.e., the emergence of Variants of Concern and Variants of Interest, novel mutations, rare double-deletion variation in the spike region (68–76del+spike 675–679del), dynamism in intrahost single nucleotide variants (iSNVs) in the severe and mild infection cohorts, immune evasion of the Mu variant and a derivative of the Delta strain with E484K and N501Y mutations, increased virulence and transmission, and the functional role of ORF8 in viral pathogenesis.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: genomic variations, transmission, pathogenesis, clinical impact, intervention
Citation: Yadav PD, Kumar S, Bergeron É and Flora MS (2023) Corrigendum: Editorial: Emerging SARS-CoV-2 variants: genomic variations, transmission, pathogenesis, clinical impact and interventions. Front. Med. 10:1260601. doi: 10.3389/fmed.2023.1260601
Received: 18 July 2023; Accepted: 20 July 2023;
Published: 27 July 2023.
Edited and reviewed by: Marc Jean Struelens, Université libre de Bruxelles, Belgium
Copyright © 2023 Yadav, Kumar, Bergeron and Flora. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pragya D. Yadav, hellopragya22@gmail.com